Skip to content

Effectiveness of manual vacuum aspiration versus pipelle biopsy for endometrial sampling in women with abnormal uterine bleeding at federal medical centre,Abeokuta

Effectiveness of manual vacuum aspiration versus pipelle biopsy for endometrial sampling in women with abnormal uterine bleeding at federal medical centre, Abeokuta.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202609862619495
Enrollment
58
Registered
2026-09-07
Start date
2026-04-29
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ENDOMETRIAL BIOPSY

Interventions

Sponsors

DR ERINOS ADEBAYO. A
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All consenting women with abnormal uterine bleeding who are referred to our reproductive health care centre (our reproductive health care centre provides the following services such as family planning clinic, endometrial sampling, colposcopy and pap smear) from the outpatient gynaecology clinic/gynaecological emergency or the peripheral hospitals for instant service for endometrial sampling after review of their preliminary results by the managing team will be enrolled for the study. These preliminary results would include pelvic ultrasound scan to rule out any exclusion criteria (submucous fibroid).

Exclusion criteria

Exclusion criteria: Patients who decline consent to participate in the study. • Pregnant women. • Women with ultrasound diagnosis of submucous fibroid. • Women with an abnormal pap smear. • Patients currently on hormonal drugs. 37 • Patients with stenotic cervical os or a history of surgery on the cervix • Patient with pelvic inflammatory disease. • Cervical cancer patient. • Menopausal women with endometrial thickness <4 mm on transvaginal sonography (TVS). • Patients on anticoagulant therapy. • Patient who reacts to misoprostol and non-steroidal anti-inflammatory drugs.

Design outcomes

Primary

MeasureTime frame
the primary outcome is assessed by the yield of the sample collected—

Secondary

MeasureTime frame
The duration of the procedure , the degree of pain during the procedure, the complications that arise during the procedure—

Countries

Nigeria

Contacts

Public ContactADEBAYO ADENIYI;ADEBAYO ADENIYI ERINOSO;ERINOSO

SENIOR REGISTRAR;SENIOR REGISTRAR

adebayoerin2@gmail.com;adebayoerin2@gmail.com+2348034993996;+2348034993996

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026